FDA approves Igalmi for at-home use for agitation in schizophrenia and bipolar disorder
David Cohen, M.D.·Published 18 November 2026·6 min read
Key points
The FDA has approved Igalmi for at-home use to manage agitation in adults with schizophrenia and bipolar disorder.
Igalmi is an oral film containing dexmedetomidine that dissolves under the tongue for quick relief from agitation.
This approval allows patients to manage symptoms at home, reducing the need for hospital visits and easing healthcare burdens.
Patients should discuss their medical history and current medications with a healthcare provider before using Igalmi.
Common side effects include drowsiness and dizziness, and serious reactions require immediate medical attention.
The FDA has approved Igalmi for at-home use, offering a new option for managing agitation in adults with schizophrenia and bipolar disorder. This approval marks a significant step forward as it provides an alternative to hospital visits for managing these symptoms. Igalmi, an oral film containing dexmedetomidine, allows patients and caregivers to manage agitation episodes in the comfort of their home.
This article delves into what this approval means, how Igalmi works, and important considerations for those considering its use. It covers frequently asked questions to help you understand the implications of this new treatment option.
What is Igalmi and how does it work?
Igalmi is an oral film containing dexmedetomidine, which is a type of medication known as a selective alpha-2 adrenergic receptor agonist. This means that it works by binding to certain receptors in the brain to produce a calming effect. Dexmedetomidine has been used in clinical settings for its sedative properties, and its use in Igalmi is designed to help manage episodes of acute agitation.
When placed under the tongue, Igalmi dissolves and enters the bloodstream, allowing it to work quickly to reduce agitation. This method of administration is convenient and can be performed without the need for medical professionals, making it particularly suitable for at-home use. The fast-acting nature of the medication helps provide rapid relief from symptoms, which can be crucial during stressful episodes.
The approval of Igalmi for at-home use provides a new option for patients who previously may have needed to visit a hospital or clinic to manage severe agitation. This can help reduce the burden on healthcare systems and provide more immediate relief for patients, improving their overall quality of life. It also offers a sense of autonomy and control for patients and their caregivers in managing the condition.
Who can benefit from using Igalmi?
Igalmi is approved for adults with schizophrenia or bipolar disorder who experience episodes of acute agitation. Individuals with these mental health conditions often face challenges with mood stability and may experience sudden and severe agitation. These episodes can be distressing for both the individual and their caregivers, often requiring prompt intervention to prevent escalation.
The use of Igalmi is intended for those who are already under the care of a healthcare provider for schizophrenia or bipolar disorder. It should be part of a comprehensive treatment plan that includes other medications and therapies as prescribed by a healthcare provider. Patients who benefit most from Igalmi are those who have frequent or severe agitation episodes that disrupt their daily lives.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
However, Igalmi is not suitable for everyone. It is crucial for patients to speak with their healthcare provider to determine if this medication is appropriate for their specific situation. Factors such as other medications being taken, medical history, and overall health need to be considered. For some, alternative treatments or additional support may be more suitable.
How should Igalmi be used at home?
Using Igalmi at home involves placing the oral film under the tongue, where it dissolves and is absorbed into the bloodstream. This sublingual method allows for quick action, which is vital in managing acute agitation. It is designed for ease of use by the patient or a caregiver, without the need for injections or other medical equipment.
It is important to follow the dosing instructions provided by the healthcare provider or as outlined on the medication's packaging. Patients should not use more than the recommended dose or use the medication more frequently than advised. Using the medication incorrectly can lead to increased side effects or reduced effectiveness.
Patients and caregivers should be aware of the onset of agitation symptoms and be prepared to administer Igalmi promptly. It is beneficial to have a plan in place, including recognizing early signs of agitation and having the medication readily available. Regular communication with a healthcare provider is also essential to monitor the effectiveness of the treatment and make any necessary adjustments.
Are there any side effects associated with Igalmi?
Like all medications, Igalmi may cause side effects. The most common side effects include drowsiness, dizziness, dry mouth, and a temporary drop in blood pressure. These effects are generally mild and resolve on their own. However, because Igalmi has sedative properties, it is important to avoid activities that require full attention, such as driving, until you know how the medication affects you.
Some individuals may experience more serious side effects, such as significant drops in blood pressure or heart rate. These are less common but require immediate medical attention. It is crucial to be aware of these potential side effects and discuss any concerns with a healthcare provider before starting Igalmi.
Patients should also inform their healthcare provider of all other medications they are taking, as interactions can occur. Certain medications, especially those that also affect the central nervous system, can enhance the sedative effects of Igalmi. A healthcare provider can help manage these interactions and adjust treatments as necessary.
What should I discuss with my doctor before using Igalmi?
Before starting Igalmi, it is important to have a thorough discussion with your healthcare provider. This conversation should cover your full medical history, including any heart problems, low blood pressure, or liver issues, as these conditions may influence the suitability of Igalmi. It is also vital to discuss any allergies or previous reactions to medications.
Your doctor will also need to know about all other medications you are currently taking, including over-the-counter drugs, supplements, and herbal products. This ensures that any potential interactions can be managed and your overall treatment plan is safe and effective.
Discussing your lifestyle and daily routines is also beneficial. Understanding how Igalmi fits into your day-to-day life can help your doctor provide the best advice on managing your condition. This includes identifying the best times to administer the medication and recognizing signs that an episode of agitation is beginning.
When should I see a doctor or seek urgent care?
It is important to know when to seek medical advice or urgent care while using Igalmi. If you or the person you are caring for experiences severe side effects such as difficulty breathing, fainting, or a significant drop in blood pressure, you should seek immediate medical attention. These symptoms can indicate a serious reaction that requires prompt intervention.
Regular follow-ups with your healthcare provider are essential to monitor your response to Igalmi and make any necessary adjustments to your treatment plan. If you notice that the medication is not effectively managing agitation or that side effects are becoming troublesome, contact your doctor for advice.
If you experience a change in mood, new or worsening depression, or thoughts of self-harm, seek help immediately. These could be signs of underlying issues that need urgent attention. Having a support system and knowing when to ask for help are key components in effectively managing mental health conditions like schizophrenia and bipolar disorder.
What are the benefits of using Igalmi for at-home treatment?
The approval of Igalmi for at-home use offers several benefits for patients with schizophrenia and bipolar disorder. The convenience of managing agitation episodes at home without needing to visit a hospital or clinic can greatly reduce stress for both patients and caregivers. This can lead to a more stable and comfortable living environment.
Having the ability to administer Igalmi at home empowers patients and their caregivers. It allows for more immediate intervention, which can prevent agitation from escalating and reduce the need for emergency care. This autonomy can be particularly beneficial for those who experience frequent agitation episodes, as it provides control over their treatment process.
Additionally, using Igalmi at home can help alleviate the burden on healthcare facilities by reducing the number of emergency visits for agitation management. This frees up resources for other patients and allows for more efficient care delivery. Overall, Igalmi adds a valuable tool for those managing schizophrenia and bipolar disorder, complementing existing therapies and improving quality of life.
Brain networks differ among those with severe schizophrenia, CAMH study shows